HighTower Advisors, LLC

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1462245 CHICAGO, IL

Position in OBIO

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$77,668

+$1,827 QoQ

Shares Held

18,275

0.0% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. OBIO ranks #78 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	870,200	$58,503,546
2	REGN	Regeneron Pharmaceuticals, Inc.	58,925	$45,527,812
3	ALNY	Alnylam Pharmaceuticals, Inc.	105,859	$35,025,567
4	VRTX	Vertex Pharmaceuticals Inc / Ma	65,684	$29,330,533
5	RPRX	Royalty Pharma plc	292,921	$14,051,420
6	AXSM	Axsome Therapeutics, Inc.	56,633	$9,572,109
7	ARWR	Arrowhead Pharmaceuticals, Inc.	146,462	$9,183,167
8	MDGL	Madrigal Pharmaceuticals, Inc.	13,914	$7,283,561

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$77,668	18,275	0.0%	Shares	Sole	2026-05-05
2025-12-31	$75,841	18,275	0.0%	Shares	Sole	2026-02-06
2025-09-30	$45,322	18,275	-72.5%	Shares	Sole	2025-11-07
2025-06-30	$178,220	66,500	+9.0%	Shares	Sole	2025-08-11
2025-03-31	$261,080	61,000	-10.9%	Shares	Sole	2025-05-13
2024-12-31	$274,000	68,500	+34.3%	Shares	Sole	2025-02-07
2024-09-30	$262,140	51,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$415,650	51,000	-3.8%	Shares	Sole	2024-08-13
2024-03-31	$279,310	53,000	+231.2%	Shares	Sole	2024-05-06
2023-12-31	$146,080	16,000	+28.0%	Shares	Sole	2024-02-12
2023-09-30	$109,000	12,500	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.